He talks about the prevalence of sudden cardiac arrest among younger athletes, how to risk stratify this population, and the controversy around using electrocardiogram imaging in standard care.
In this commentary, Michael Bloch, MD, writes about using time in therapeutic range (TTR) to determine dose, dietary recommendations, and a possible need to change anticoagulants for patients on warfarin.
...
How do patterns of blood pressure change over the life course and differ between men and women? A new analysis contradicts what you think you know. Lead researcher Susan Cheng, MD, MPH, MMSc, offers her...
Luke Joseph Laffin, MD, from the Cleveland Clinic Foundation, answers our questions about his research on the effect of phase 2 cardiac rehabilitation on exercise capacity and outcomes in patients with...
Andres Pineda Maldonado, MD, from the University of Florida, Jacksonville, answers our questions about new therapies for mitral valve disease, the different recommendations for men vs women, and more.
What are the associations between Takotsubo syndrome and cannabis use? In this Q&A, Rupak Desai, MBBS, explains what he and his research team discovered about the relationship and how their results...
James J. Matera, DO, explains the importance of treating hyperkalemia – a common occurrence in patients with chronic kidney disease – in the context of comorbid cardiometabolic disease.
In this article, Michael J. Bloch, MD, writes about studies over the past 30 years that prove lower achieved blood pressure, including modest reductions in blood pressure, translates to lower cardiovascular...
The medical community is uniquely positioned to help combat the spread of medical misinformation. Now that online groups opposed to proven medical interventions are taking aim at statins, here is what...
While SGLT-2 inhibitors are often used in patients with type 2 diabetes, this class of medication can also be used to treat patients with heart failure. In this Q&A, Jennifer Clements, PharmD, discusses a...
